Key facts
- It has raised $5.9M; the latest was Seed Round ($5.9M) in Apr 2025.
- Notable investors include Project A Ventures, Amino Collective, Boris Lokschin, Timo Flebner, helloworld (VC).
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Rematiq
- ·The full record, as it builds
Funding rounds
No funding rounds for Rematiq are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rematiq
Developer of workflow automation software designed to streamline regulatory processes along with the product lifecycle. The company's platform offers impact and gap analysis, requirements management, regulatory intelligence, and change management, enabling medical innovators to reduce regulatory complexity at critical points across the product lifecycle.
- Sector
- Information Technology
- HQ
- Berlin, Germany
- Founded
- 2023
- Employees
- 17
- Website
- rematiq.com/
- Ownership
- Privately Held (backing)
Rematiq doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rematiq shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rematiq in its N-PORT filings yet. We sweep new filings monthly.